November 9, 2022 Allergy/Immunology Researchers seek to understand why vaccine responses vary from person to person
November 2, 2022 Vaccines Pfizer RSV vaccine data submitted to FDA for evaluation. Large international study found vaccinating during pregnancy was nearly 82% effective at preventing severe RSV cases in their babies’ first 90 days of life, 69% at 6 months.
October 18, 2022 Vaccines BioNTech founders say their company is working on adapting mRNA technology to produce cancer-fighting vaccines. They hope to have something by 2030.
September 26, 2022 General information Bivalent COVID vaccine now available to all Ontarians over 18 years of age. Why do we have the bivalent BA.1 version whilst the US has the BA.4 and 5?
August 22, 2022 Epidemiology CDC urges polio vaccination as it has been detected in wastewater samples in and around New York City.
August 16, 2022 Health Policy New Moderna BA.1 variant vaccine approved for use in UK. We will likely see BA.4 and BA.5 omicron subvariant versions here as U.S. FDA wants the latter versions included in any vaccine submitted for their approval.
August 10, 2022 Allergy/Immunology A vaccine for Lyme disease is in its Phase 3 trial. Results to date show efficacy and safety. If trial is successful, official authorization expected in 2025.
July 14, 2022 Health Policy Fourth COVID vaccine dose now open to all adults in Ontario who choose to do so. Who should partake in this option? @billcarrolltalk and I discuss the assumptions being made and why for most, you should opt in.
July 4, 2022 Health Policy Fourth COVID vaccine dose should be available to all adults who want it just as Quebec has done.